KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Exchange Rate Effect (2016 - 2025)

Pfizer (PFE) has disclosed Exchange Rate Effect for 17 consecutive years, with $5.0 million as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect changed N/A to $5.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $41.0 million through Dec 2025, changed N/A year-over-year, with the annual reading at $41.0 million for FY2025, 162.12% up from the prior year.
  • Exchange Rate Effect for Q4 2025 was $5.0 million at Pfizer, up from $2.0 million in the prior quarter.
  • The five-year high for Exchange Rate Effect was $41.0 million in Q2 2025, with the low at -$139.0 million in Q4 2022.
  • Average Exchange Rate Effect over 5 years is -$19.7 million, with a median of -$6.0 million recorded in 2023.
  • The sharpest move saw Exchange Rate Effect plummeted 1420.0% in 2022, then skyrocketed 327.78% in 2025.
  • Over 5 years, Exchange Rate Effect stood at -$32.0 million in 2021, then plummeted by 334.38% to -$139.0 million in 2022, then skyrocketed by 99.28% to -$1.0 million in 2023, then tumbled by 3600.0% to -$37.0 million in 2024, then surged by 113.51% to $5.0 million in 2025.
  • According to Business Quant data, Exchange Rate Effect over the past three periods came in at $5.0 million, $2.0 million, and $41.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.